New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (147% increase in shares outstanding). Market cap is less than US$10m (UK£2.66m market cap, or US$3.60m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Revenue is less than US$5m (UK£1.0m revenue, or US$1.4m). Ankündigung • Jan 14
Metir plc Provides Earnings Guidance for the Financial Year Ended December 31, 2025 Metir plc provided earnings guidance for the financial year ended December 31, 2025. for the year, the company expects to report revenues of £1.5 million. Ankündigung • Dec 22
Metir plc has completed a Follow-on Equity Offering in the amount of £1 million. Metir plc has completed a Follow-on Equity Offering in the amount of £1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 126,666,666
Price\Range: £0.0075
Security Features: Attached Warrants
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 6,666,667
Price\Range: £0.0075
Security Features: Attached Warrants
Transaction Features: Subsequent Direct Listing Ankündigung • Nov 21
Metir plc Appoints Claire Smith as Chief Financial Officer, Effective November 19, 2025 Metir plc announced the appointment of Claire Smith as Chief Financial Officer with immediate effect on November 19, 2025, alongside key hires to grow its business development function. All appointments are non-Board at this time. Claire brings over 25 years of financial and operational experience. Most recently, she served as Chief Executive Officer and previously as Chief Financial Officer and Company Secretary of Zytronic plc, an AIM-listed manufacturer of touch sensor products. During her tenure, she led finance, HR and IT functions. Before her role at Zytronic, Claire held finance positions with the NAAFI and Procter & Gamble, working both in the UK and Germany. Claire holds a B.A. (Hons) degree in Business and Finance from Northumbria University. She qualified as a Chartered Management Accountant in 2006 and obtained a Certificate in International Cash Management in 2011. Board Change • Nov 06
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Chris Potts was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Jul 11
Metir plc, Annual General Meeting, Aug 12, 2025 Metir plc, Annual General Meeting, Aug 12, 2025. Location: the offices of turner pope investments tpi limited, 3 queen street, w1j 5pa, london United Kingdom Ankündigung • Jun 10
Metir plc has completed a Follow-on Equity Offering in the amount of £0.85 million. Metir plc has completed a Follow-on Equity Offering in the amount of £0.85 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 120,000,000
Price\Range: £0.0065
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 10,769,231
Price\Range: £0.0065
Transaction Features: Subsequent Direct Listing Ankündigung • Feb 06
Microsaicsystems plc Announces Board Changes MicrosaicSystems plc announced that Dr. Christopher ("Chris") Potts will join the board as Independent Non-Executive Director with immediate effect. Bob Moore remains in the role of Executive Chairman and acting Chief Executive Officer pending the appointment of a new Non-Executive Chairman as planned and to be announced in due course. Dr. Chris Potts brings over 20 years of senior executive and chair experience of international technology businesses. He is presently Chair of proSapient Ltd, a world leading service company based in the UK, with offices in the US, Canada and Portugal, utilising artificial intelligence technology to search for and engage experts who can assist in due diligence processes for leading global management consultancies and private equity firms. He is also Chair of Zytronic plc; a UK based manufacturing company which supplies sophisticated touch screen technology to a global market. Before that, he was Chair of Guralp Systems limited, a UK based firm which designs, manufactures, and installs seismic sensors for customers globally, for nine years. Chris's prior CEO experience includes leading privately owned firms, private equity backed businesses and divisions of listed public companies. He has a proven track record of steering manufacturing, software development, and service-based firms, while managing diverse, multidisciplinary teams of technical, scientific, and business leaders. He has led several large international corporate transactions. He has also served as a trustee or non-executive director of three university or educational institutions. Academic and research credentials include a PhD from the University of Cambridge, an MBA from Cranfield School of Management, and published papers in international peer-reviewed scientific journals.
Christopher Graeme Potts (aged 68) is currently, or has during the past five years been, a director of the following companies: Current directorships or partnerships: Zytronic plc. ProSapient Limited. The American University of Bulgaria. Previous directorships or partnerships: Goodhind Bullard Limited, Guralp Systems Limited ("GSL"), Guralp Finance Limited, Guralp Holdings Limited, Guralp Systems Inc, Moller Institute Limited and Guralp Systems GmbH. Ankündigung • Nov 15
Microsaic Systems plc, Annual General Meeting, Dec 11, 2024 Microsaic Systems plc, Annual General Meeting, Dec 11, 2024. Location: the offices of turner pope investments tpi limited, 3 queen street, w1j 5pa, london United Kingdom Ankündigung • Jan 26
Microsaic Systems plc (AIM:MSYS) acquired certain assets of DeepVerge plc and certain assets of Innovenn Limited from DeepVerge plc and Innovenn Limited for £0.1 million. Microsaic Systems plc (AIM:MSYS) announced the acquisition of certain assets of DeepVerge plc and certain assets of Innovenn Limited from DeepVerge plc and Innovenn Limited for £0.1 million on January 12, 2024. Completion is subject to various conditions including Admission and the delivery of several intellectual property assignments to the benefit of the Company by no later than January 24, 2024. Aubrey Powell, Angus Campbell and Oliver Platts of Singer Capital Markets Limited acted as financial advisor to Microsaic Systems plc. Andy Thacker and James Pope of Turner Pope Investments (TPI) Limited acted as joint broker in the transaction.Microsaic Systems plc (AIM:MSYS) completed the acquisition of certain assets of DeepVerge plc and certain assets of Innovenn Limited from DeepVerge plc and Innovenn Limited on January 25, 2024. Ankündigung • Jan 13
Microsaic Systems plc to Report Second Half, 2023 Results on Jan 15, 2024 Microsaic Systems plc announced that they will report second half, 2023 results on Jan 15, 2024 Ankündigung • Dec 04
Microsaic Systems plc, Annual General Meeting, Dec 19, 2023 Microsaic Systems plc, Annual General Meeting, Dec 19, 2023, at 09:30 Coordinated Universal Time. Location: Turner Pope Investments at 8 Frederick's Place, London, EC2R 8AB London United Kingdom Agenda: To consider Share Consolidation and Sub-division; to consider Cancellation Resolution; to consider Board composition; to consider Additional requirements for restoration; to consider Process for, and principal effects of, the Fundraising; and to transact such other business matters. Ankündigung • Nov 07
Microsaic Systems Intends to Delist Microsaic Systems plc is planning to cancel admission to trade of its shares on AIM. The cost reduction plans include the Company's intention to cancel admission to trading of its shares on AIM ("Delisting"), subject to shareholder approval at a general meeting, notice of which is expected to be published as soon as reasonably practicable. This action is being taken to minimise costs and preserve cash resources in the continuing business. The Company will continue to meet its obligations under the AIM Rules for Company until cancellation has taken effect. The Company is also exploring alternative 'matched bargain facilities' to enable investors to trade in its shares following the intended Delisting, although the timing for implementation and details of operation of such a facility are not yet known, and the facility could, if implemented, be withdrawn in future at the Company's discretion. Microsaic expects that the cost reductions being made will enable it to publish its annual report and accounts for the year ended 31 December 2022 ("FY22") on a going concern basis, although the timing of this is imprecise and remains subject to audit sign-off. As a result of this uncertainty and the additional costs associated with concluding the FY22 audit and with publishing interim accounts to June 2023 as a publicly quoted company, the Company does not currently consider that it will be in a position to seek reinstatement to trading of the Company's shares on AIM in before the Delisting occurs. The Company will continue to seek additional capital as a private company, both to support working capital needs and potentially also to support growth initiatives. To the extent possible, Microsaic would consider mechanisms to allow existing shareholders to participate in such fundraising event(s). Alternate transactions including business combinations, joint ventures and licensing arrangements would also be considered. As at 1 November 2023, the Company has cash in the bank of approximately £160k with no debt, and continues to meet its obligations as they fall due. Further information on the effects of the proposed Delisting on the Company and its implications for shareholders will be provided in the circular being prepared to give notice of the general meeting ("GM") required to give effect to the Delisting (the "Circular"). GM will be held to approve the delisting on November 24, 2023. Ankündigung • Sep 25
Microsaic Systems plc Announces Directorate Change Microsaic Systems plc announced that Gerry Brandon, Executive Chairman, has resigned and will leave the Company and the Board with immediate effect, to enable him to devote more time to his other business commitments.Gerry joined the Company in January 2021 and has been instrumental in the transformation of the Company to be a commercially focused service provider as well as a mass spectrometry manufacturing business. The Company announced the appointment of Bob Moore, who joined the Company as a Non-Executive Director in March 2022, as Executive Chairman. In addition to the above management changes, the Company intends to progress with the recruitment of a new CEO to ensure that the Company has the full set of skills necessary to take the business forward and return to compliance with the appropriate corporate governance standards. At that time it is expected that Bob Moore would revert to a non-executive role. Board Change • Nov 16
Less than half of directors are independent There are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 8 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Member of Scientific Advisory Board Neil Spooner is the most experienced director on the board, commencing their role in 2017. Independent Non-Executive Director Bob Moore was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Reported Earnings • Sep 30
First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021) First half 2022 results: EPS: UK£0 (in line with 1H 2021). Revenue: UK£734.9k (up 47% from 1H 2021). Net loss: UK£704.7k (loss narrowed 67% from 1H 2021). Ankündigung • Jun 01
Microsaic Systems plc, Annual General Meeting, Jun 30, 2022 Microsaic Systems plc, Annual General Meeting, Jun 30, 2022, at 09:00 Coordinated Universal Time. Location: 8 Frederick's Place London . United Kingdom Reported Earnings • May 31
Full year 2021 earnings released: UK£0.001 loss per share (vs UK£0.005 loss in FY 2020) Full year 2021 results: UK£0.001 loss per share. Revenue: UK£906.9k (up 357% from FY 2020). Net loss: UK£3.13m (loss widened 32% from FY 2020). Board Change • Apr 27
Less than half of directors are independent There are 3 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 new directors. 8 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). Member of Scientific Advisory Board Neil Spooner is the most experienced director on the board, commencing their role in 2017. Independent Non-Executive Director Bob Moore was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Recent Insider Transactions Derivative • Feb 16
Non-Executive Director exercised options to buy UK£250k worth of stock. On the 11th of February, Nigel Burton exercised options to buy 200m shares at a strike price of around UK£0.001, costing a total of UK£200k. This transaction amounted to 199% of their direct individual holding at the time of the trade. Since September 2021, Nigel has owned 65.50m shares directly. This was the only transaction from an insider over the last 12 months. Ankündigung • Jan 29
Microsaic Systems plc Announces Resignation of Glenn Tracey, Chief Executive Officer Microsaic announced that, after what will have been over 7 years of service, Glenn Tracey, has notified the Board that he will be stepping down from his role as Chief Executive Officer ("CEO") with effect from the date of the Company's next Annual General Meeting ("AGM"), to pursue a non-competitive opportunity. Until that time, Glenn will remain as CEO and Director. The Company and Glenn will also co-ordinate an orderly handover of his responsibilities during this period. The Company will shortly therefore commence a formal process to identify and appoint a successor CEO. Pending this appointment and to support the orderly handover in due course, Gerry Brandon, Non-executive Chairman, will temporarily play a more active role in the running of Microsaic's business. Ankündigung • Jul 03
Microsaic Systems plc Announces Development of Real-Time Monitoring Solution Microsaic Systems plc announced the development and demonstration of the first, real-time monitoring Process Analytical Technology ("PAT") MS solution for the on-line production of biotherapeutic drugs such as vaccines and anti-cancer treatments. Live data transmitted via Internet of Things ("IoT") devices from the micro-engineered MS equipment, enables constant monitoring of production processes, to ensure high quality biological production output. This real-time alert system allows rapid scaling to large volumes, reduces supervision costs, and accelerates vaccines and anti-cancer treatments through emergency and standard regulatory authorisation and direct to patients. Reported Earnings • May 05
Full year 2020 earnings released: UK£0.005 loss per share (vs UK£0.006 loss in FY 2019) The company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: UK£198.3k (down 77% from FY 2019). Net loss: UK£2.37m (loss narrowed 15% from FY 2019). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings. Executive Departure • Feb 11
Independent Non-Executive Chairman Peter Grant has left the company On the 5th of February, Peter Grant's tenure as Independent Non-Executive Chairman ended after 3.1 years in the role. As of September 2020, Peter personally held only 750.00k shares (UK£4.5k worth at the time). A total of 2 executives have left over the last 12 months. Recent Insider Transactions • Feb 06
Insider recently bought UK£5.0m worth of stock On the 5th of February, Gerard Brandon bought around 50m shares on-market at roughly UK£0.10 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£8.3m more in shares than they have sold in the last 12 months. Ankündigung • Feb 05
Microsaic Announces Board Changes Microsaic announced that, further to the fundraise announcements on 19 January 2021 and the passing of the resolutions at the General Meeting held on February 4, 2021, Gerard Brandon and Dr. Nigel Burton are appointed to the Board of the Company as Non-Executive Chairman and Non-executive Director respectively, with effect from February 5, 2021. The Finance & Audit and Remuneration Committees will be chaired by Dr. Nigel Burton, and Gerard Brandon will be a member of both committees. Dr. Nigel Burton will assume the responsibilities of Senior Non-Executive Director. These arrangements will be reviewed when an independent Non-executive Director joins the Board. Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc ("Alltracel"), where he built a team which oversaw numerous patents granted on refined cellulose. Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc. As anticipated in the Circular published on 19 January 2021, Peter Grant, Non-executive Chairman and Eric Yeatman, Non-executive Director, stepped down from the Board with effect from February 5, 2021. Eric Yeatman will be retained as a consultant. Recent Insider Transactions • Dec 12
Insider recently sold UK£195k worth of stock On the 7th of December, Colin Nicholl sold around 500k shares on-market at roughly UK£0.39 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of UK£203k more than they bought in the last 12 months.